Investor
Ideas Potcasts, Cannabis News and Stocks on the Move; Episode 412 (OTC: $CSUI)
(TSX: $FAF.TO) (CSE: $PILL.C) (CSE:
$CURA.C) (TSX: $FIRE.TO) (OTCQX: $SPRWF)
(CSE: $BLO.C)
Delta, Kelowna, BC, May 11, 2020 (Investorideas.com Newswire) www.Investorideas.com,
a global news source covering leading sectors including marijuana and hemp
stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight
from thought leaders and experts.
Listen to the podcast:
Read this in full
at https://www.investorideas.com/news/2020/cannabis-potcasts/05111CSUI-FAF-PILL-CURA-FIRE-SPRWF-BLO.asp
Today’s podcast overview/transcript:
Good
afternoon and welcome to another episode of Investorideas.com
"Potcast" featuring cannabis news, stocks to watch as well as
insights from thought leaders and experts.
Today’s
podcast is sponsored by Cannabis Suisse
Corp. (OTC: CSUI), a research &
development company licensed under Swiss Cannabis and tobacco regulations to
cultivate and sell cannabis. The Company's facilities for producing cannabis
are based in Zurich.
The
Company grows high quality, organic cannabis with sustainable, all-natural
principles. Cannabis Suisse products are laboratory tested to ensure the end
users have access to a standardized, safe and consistent product.
In
today’s podcast we will be looking at a few public company announcements.
Fire
& Flower Holdings Corp. (TSX:
FAF)
(OTCQX:
FFLWF), and its indirect wholly-owned subsidiary Hifyre™
Inc., today
announced that the Spark Perks™ member program has achieved the
milestone of 100,000 enrolled members across the Fire & Flower retail
network.
Spark Perks offers
its members access to services including Spark Fastlane™
"click-and-collect", curbside pickup and the Rapid Delivery™ home
delivery service in jurisdictions where these programs are permitted. In
addition, member benefits include exclusive discounts, member-only content and
access to invite-only events.
On average, Spark
Perks members spend 37% more per transaction than non-members and have
purchased from Fire & Flower an average of 2.5 times in the past seven
weeks. More than 50% of all Fire & Flower transactions are from Spark Perks
members.
Sparks Perks continues
to be a competitive advantage for Fire & Flower and since the onset of the
COVID-19 public health crisis beginning in March 2020, more than 20,000 members
have enrolled in the program.
"The Hifyre
platform continues to be a competitive advantage for Fire & Flower in
cannabis retailing. Engaged customers, repeat purchasing and higher than
average transaction values are key in building our Retail Platform revenue
stream," shared Trevor Fencott, Chief Executive Officer of Fire &
Flower. "As consumer behaviours and preferences change towards increased
digital engagement, Fire & Flower is well positioned to maximize market
opportunities."
Canntab
Therapeutics Limited (CSE:PILL)(OTCQB:CTABF), the
leading innovator in cannabinoid and terpene blends in hard pill form for
therapeutic applications, announced that
Mr. Larry Latowsky, Special Advisor and future Executive Chairman of the Board
of Directors of the Company (pending Health Canada approval), will present via
webcast at the Canaccord Genuity 4th Annual Cannabis Conference, on Tuesday,
May 12, 2020, at 9:20 a.m. (EST).
Mr.
Latowsky's presentation is expected to discuss, among other things, the
Company's top priorities, and strategic plans for the future.
"Many
companies solicited my support and directorships, but I joined Canntab half a
year ago because of my belief in Canntab's business model and its distinctive
product offerings. Canntab's medical cannabis solutions, which will be critical
to the adoption of cannabinoids by the medical community, place Canntab in a
unique position to execute on significant opportunities that will generate
sustainable value for all stakeholders," explains Larry Latowsky, Special
Advisor and future Executive Chairman of the Board, pending Health Canada
approval.
Mr.
Latowsky brings decades of experience in the manufacturing, wholesale and
distribution of pharmaceutical and nutraceutical products, having previously
served as the President and CEO of Drug Trading Co., and Katz Group Canada, the
parent company of, among others, Rexall Pharmaplus.
The
webcast of the Company's presentation will be available at: http://wsw.com/webcast/canaccord39/ctabf/
Curaleaf Holdings, Inc.
(CSE:
CURA) (OTCQX:
CURLF), a leading vertically integrated cannabis operator in
the United States, today
announced an agreement with Mango Cannabis, the top
medical cannabis dispensary in Oklahoma, to distribute Curaleaf's Select brand
products. The brand is being distributed for the first time in Oklahoma at two
Mango Cannabis dispensaries in Edmond and Tulsa.
Select,
which was acquired by Curaleaf in February 2020, currently retails in Oregon,
California, Nevada, Arizona, Colorado, Michigan, Maryland and Oklahoma. The
brand is expanding across the country in the 17 states where Curaleaf operates.
Select is initially launching in the Oklahoma market with its 1g Elite
cartridge, the brand's most popular product that delivers an activated,
broad-spectrum oil with a high THC level. The brand plans to offer Elite Live
and other new products to Oklahoma medical patients in the near future.
"We
are excited to launch our Select brand in Oklahoma through our partnership with
Mango Cannabis, a trusted dispensary in the state," said Joe Bayern,
President of Curaleaf. "As we focus on expanding the Select brand,
entering Oklahoma allows us to reach an important and rapidly evolving medical
marijuana market. We look forward to serving the health and well-being of
medical patients in Oklahoma."
During
the COVID-19 pandemic, cannabis businesses have been deemed an essential
service in most states, including Oklahoma. Curaleaf remains committed to
serving patients and customers with the products they rely on while
implementing heightened safety and hygienic measures in all its facilities.
7ACRES,
a division of The Supreme Cannabis
Company, Inc. (TSX: FIRE) (OTCQX:
SPRWF) announced the
launch of meetyourtastebuds.com, an
interactive website designed to help consumers across the country find the
perfect strain.
Whether
consumers have enjoyed cannabis for years or just recently started their
cannabis journey, 7ACRES is encouraging everyone to focus on what tastes
delicious. Cannabis shares common flavours with many items people eat or drink
every day, such as citrus and spice. By answering a few questions about your
individual taste preferences at meetyourtastebuds.com, consumers will receive a
personalized recommendation of a 7ACRES cultivar specifically selected for
them.
"We
are very excited to launch this interactive tool and help consumers distinguish
their cannabis taste preferences. Taste plays a big part in a user's cannabis
experience and, along with look and smell, can be a good differentiator of
quality cannabis," said Nicole Sale, VP, Marketing & Communications.
"During this difficult time of social distancing, consumers may not be
able to engage budtenders as easily as they used to. Meetyourtastebuds.com can
act as another source of information for those shopping from home."
Since
legalization, many consumers have come to believe that THC is the primary trait
to distinguish high quality from low quality cannabis strains. While THC can be
important, so is the look, smell and taste of the flower. Strong, pungent
sensory characteristics are key indicators of high end cannabis and should also
be considered when purchasing. 7ACRES grows cannabis cultivars that respect the
plant, offering unique aromatic notes and complex flavours to satisfy a wide variety
of tastes. Cannabis is complex but finding a strain that excites consumers
taste buds shouldn't be.
Cannabix
Technologies Inc. (CSE:
BLO)
(OTC:
BLOZF), developer of marijuana breathalyzer devices for law
enforcement and the workplace, reported
that the Company has developed a new version of its THC Breath Analyzer
(“THCBA”) and is preparing for additional testing with the device. Company
engineers have updated several components in the THCBA and have changed the
form factor for improved handling. Cannabix Technologies is on the forefront in
research and development to create point-of-care breath testing technologies
for the detection of ∆9-tetrahydrocannabinol (“THC”) - the psychoactive
component of marijuana that causes impairment. The THCBA incorporates
microfluidic sensor technology for the detection of THC from breath. New
pictures of the THCBA version 2.0 advanced prototype device are available on
the Company’s website (www.cannabixtechnologies.com).
The
THCBA has attractive features such as single-hand ergonomic design and
single-stage direct breath capability.
Testing to date, has shown from the time of sample intake, the device
can provide results in under 5 minutes. The THCBA uses a disposable spit trap
and provides easy to understand screen prompts for the positive and negative
detection of THC in breath. Studies¹
have shown that breath is a better indicator of impairment than saliva, blood,
or urine because THC is present in breath for a relatively short period of time
(1-3 hours); whereas, it is excreted at detectable levels in other body fluids
for many hours, days, or even weeks after smoking. This short time period of
detection in breath aligns with the peak impairment window. The Company has
been developing the THCBA with Dr. Mina Hoorfar at University of British
Columbia (“UBC”) and has an exclusive technology license agreement with UBC.
In
the immediate term, Cannabix scientists will be testing the THCBA 2.0 device
with cannabis smokers in order to (a) have more cannabis user data to enhance
the device’s machine learning database and (b) for continuous improvement
purposes. It should be noted that testing with cannabis smokers under general
COVID-19 restrictions in place has become more time-consuming as device
sterilization and organizing multi-subject testing has become more onerous. In
the THCBA 2.0 version, several components have been built using 3D printed
technology for rapid prototyping and design flexibility, and engineers have begun
experimenting with different materials and coatings that would be more
advantageous in manufacturing processes.
Since early March, our discussions with potential pilot/test-user groups
were paused due to the COVID-19 pandemic, however the Company is pleased to
report it is having renewed discussions with pilot-use cases and is actively
navigating how such studies will be done with enhanced safety in mind.
Rav
Mlait, CEO, stated, “Our team has been diligently pressing forward with
development of our marijuana breathalyzer devices through the various
constraints that the COVID-19 pandemic has presented to us and our suppliers.
We have improved the design and form factor of the THCBA and look forward to
collecting more user data.”
Once again, today’s
podcast was sponsored by Cannabis Suisse
Corp. (OTC: CSUI), a
research & development company licensed under Swiss Cannabis and tobacco
regulations to cultivate and sell cannabis. The Company's facilities for
producing cannabis are based in Zurich.
The
Company grows high quality, organic cannabis with sustainable, all-natural
principles. Cannabis Suisse products are laboratory tested to ensure the end
users have access to a standardized, safe and consistent product.
Investor
ideas reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com
website and this podcast is not an endorsement to buy products or services or
securities. Investors are reminded all investment involves risk and possible
loss of investment
Learn more about
our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
Investorideas.com
podcasts are also available on iTunes,
Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified
word mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that
Inspires Big Investing Ideas
Investorideas.com
is a recognized news source publishing third party news, research and original
financial content. Learn about investing in stocks and sector trends with our
news alerts, articles, podcasts and
videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water,
renewable energy and more. Investor Idea’s original branded content includes
the following podcasts and columns : Crypto Corner , Play
by Play sports and stock news column, Investor Ideas
Potcasts Cannabis News and Stocks on the Move podcast and
column, Cleantech
and Climate Change , Exploring
Mining the AI
Eye .
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions. Disclosure: CSUI is a paid monthly news and social media
client on investorideas.com More disclaimer info:
https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other
news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations
of each country. Please read Investorideas.com privacy policy:
Investor Ideas does not condone the use of
cannabis except where permissible by law. Our site does not possess,
distribute, or sell cannabis products.
Contact Investorideas.com
800
665 0411
No comments:
Post a Comment